Jon Lenn, before being appointed CTO, was previously the Senior Vice President of US Operations where he led the creation and growth of MedPharm US subsidiary in RTP, North Carolina from its inception in 2016. Jon is well established as authority in pharmaceutical development of topical products having started his career in Connetics before having roles of increasing responsibility in Stiefel and GlaxoSmithKline. In his new role, Jon will be focused on coordinating MedPharm’s technological innovation strategy particularly in the area of automation and performance testing to ensure MedPharm stays at the forefront of these scientific disciplines.
Haydn Sinclair is re-joining MedPharm to oversee all aspects of MedPharm’s quality system which encompasses both of MedPharm’s sites in North Carolina, USA and Guildford, UK. The capabilities of both sites are continuing to increase in parallel with MedPharm’s growth as an organisation. Haydn will be responsible for ensuring that the quality system remains at the high standard expected by MedPharm’s customers and is sufficiently flexible to accommodate the different requirements of formulation development, performance testing, and clinical manufacture. Additionally, Haydn will be responsible for maintaining all of MedPharm’s quality accreditations including GLP and cGMP.
“These two appointments reflect MedPharm’s desire to ensure we have the right people to lead all aspects of business as we continue to grow and offer more services to our clients”, comments Prof Marc Brown, MedPharm’s CSO and co-founder. “They show that MedPharm is developing as a global organisation.”
About MedPharm
MedPharm Ltd. is a leading, global provider of contract topical and transdermal product design and formulation development services. MedPharm are experts at reducing risk and accelerating development times for generic and proprietary pharmaceutical customers through proprietary, industry-leading performance testing models. Well-established as a global leader in dermatology, nail, mucosal membrane, and transdermal product development, MedPharm also offers innovative solutions for ophthalmic and airway preparations. These solutions are recognised for their scientific rigor by regulators and investors. MedPharm has fully established R&D centres in the US and U.K. and GMP clinical manufacturing at its global headquarters facility in Guildford, UK.